Status:
COMPLETED
Modifications in the Anaerob Threshold in Cyclists by Consuming Docosahexaenoic Acid (DHA)
Lead Sponsor:
Universidad Católica San Antonio de Murcia
Conditions:
Performance
Eligibility:
MALE
18-45 years
Phase:
NA
Brief Summary
In a double-blind, parallel randomized clinical trial with 38 cyclists in whom the performance improvement was determined after the consumption of docosahexaenoic acid for one month.
Eligibility Criteria
Inclusion
- Male between 18 and 75 years old.
- Cyclists who train three or four times a week.
Exclusion
- Suffering some type of chronic disease.
- Consume habitually pharmacological treatments that could influence the physiological or biochemical responses to be analyzed in the present work.
- Consumption in the month prior to the start of the study, or during the performance of the same, functional food enriched with omega-3 fatty acids.
- To present during the performance of the stress tests, any of the absolute or relative contraindications dictated by the American College of Sports Medicine (ACSM, 1999) 15 would be duly informed and excluded from the present study.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04128449
Start Date
April 1 2018
End Date
June 30 2018
Last Update
October 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Catholic University of Murcia
Murcia, Spain, 30107